AU1915100A - A method of genetic vector delivery - Google Patents

A method of genetic vector delivery

Info

Publication number
AU1915100A
AU1915100A AU19151/00A AU1915100A AU1915100A AU 1915100 A AU1915100 A AU 1915100A AU 19151/00 A AU19151/00 A AU 19151/00A AU 1915100 A AU1915100 A AU 1915100A AU 1915100 A AU1915100 A AU 1915100A
Authority
AU
Australia
Prior art keywords
vector delivery
genetic vector
genetic
delivery
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19151/00A
Inventor
Raymond T Bartus
E. Antonio Chiocca
Keiro Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Alkermes Inc
Original Assignee
General Hospital Corp
Alkermes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Alkermes Inc filed Critical General Hospital Corp
Publication of AU1915100A publication Critical patent/AU1915100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU19151/00A 1998-11-17 1999-11-17 A method of genetic vector delivery Abandoned AU1915100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10888198P 1998-11-17 1998-11-17
US60108881 1998-11-17
PCT/US1999/027206 WO2000029033A2 (en) 1998-11-17 1999-11-17 A method of genetic vector delivery

Publications (1)

Publication Number Publication Date
AU1915100A true AU1915100A (en) 2000-06-05

Family

ID=22324608

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19151/00A Abandoned AU1915100A (en) 1998-11-17 1999-11-17 A method of genetic vector delivery

Country Status (2)

Country Link
AU (1) AU1915100A (en)
WO (1) WO2000029033A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539257A (en) 1999-03-19 2002-11-19 イーノス・ファーマシューティカルス・インコーポレーテッド Increased drug bioavailability in the brain
US20070190032A1 (en) * 2006-02-13 2007-08-16 Oncolytics Biotech Inc. Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
US8703136B2 (en) * 2006-10-10 2014-04-22 Regenesance B.V. Complement inhibition for improved nerve regeneration
US20230242887A1 (en) * 2017-08-09 2023-08-03 Ohio State Innovation Foundation Oncolytic virus carrying e-cadherin and uses thereof
EP3996744A4 (en) * 2019-07-05 2023-07-12 Apellis Pharmaceuticals, Inc. Viral vector therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866042A (en) * 1987-11-18 1989-09-12 Neuwelt Edward A Method for the delivery of genetic material across the blood brain barrier
EP0804076A4 (en) * 1994-10-19 1998-10-21 Genetic Therapy Inc Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents

Also Published As

Publication number Publication date
WO2000029033A3 (en) 2000-10-05
WO2000029033A2 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU5153296A (en) Vectors for gene delivery
EP0921661A3 (en) Routing method using a genetic algorithm
AU6386796A (en) A lipidic vector for nucleic acid delivery
AU4024595A (en) A genetic method of scheduling the delivery of non uniform inventory
AU4172599A (en) A process for inhibiting expression of genes
AU5671696A (en) Scytalidium catalase gene
AU2466299A (en) A new human tumor-associated gene
AU3745599A (en) Noncloning technique for expressing a gene of interest
AU6229098A (en) Cancer-associated genes
AU9089398A (en) New plant genes
AU4397797A (en) Method of gene introduction
AU1915100A (en) A method of genetic vector delivery
AU1106500A (en) Alpha-2/delta gene
AUPP670698A0 (en) A method of regulation
AU2208199A (en) Cloning of a high growth gene
AUPO882497A0 (en) A method of genotyping
AU6793598A (en) Glycosylceramide-containing liposomes
AU1314201A (en) A method of selective viewing
AU7372498A (en) Entomopoxvirus-based gene delivery vector for vertebrates
AU7558998A (en) Method for reinforcing
AUPP526898A0 (en) A plant regulatory gene
GB9706469D0 (en) Genetic method
AU1292301A (en) Method for genetic manipulation
AUPP058797A0 (en) Novel gene
AUPP470898A0 (en) A regulatory gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase